Difference between revisions of "Category:KIT inhibitors"
Jump to navigation
Jump to search
m |
m |
||
| Line 1: | Line 1: | ||
A class of drugs that inhibit the proto-oncogene c-Kit, also called mast/stem cell growth factor receptor. Actionable mutations of KIT are seen in [[Sarcoma|gastrointestinal stromal tumors]], [[Mast cell diseases|mast cell disease]], [[Testicular cancer|seminoma]], [[Melanoma|melanoma]], and [[Acute myeloid leukemia|acute myeloid leukemia]] | A class of drugs that inhibit the proto-oncogene c-Kit, also called mast/stem cell growth factor receptor. Actionable mutations of KIT are seen in [[Sarcoma|gastrointestinal stromal tumors]], [[Mast cell diseases|mast cell disease]], [[Testicular cancer|seminoma]], [[Melanoma|melanoma]], and [[Acute myeloid leukemia|acute myeloid leukemia]] | ||
| + | [[Category:Growth factor inhibitors]] | ||
[[Category:Kinase inhibitors]] | [[Category:Kinase inhibitors]] | ||
Revision as of 03:40, 23 July 2017
A class of drugs that inhibit the proto-oncogene c-Kit, also called mast/stem cell growth factor receptor. Actionable mutations of KIT are seen in gastrointestinal stromal tumors, mast cell disease, seminoma, melanoma, and acute myeloid leukemia
Pages in category "KIT inhibitors"
The following 21 pages are in this category, out of 21 total.